Shots: Symbiosis will provide AstraZeneca access to its sterile vaccine drug product manufacturing capacity for clinical trial supply The agreement follows AstraZeneca’s licensing agreement with the University of Oxford for the global development, manufacturing, and distribution of the AZD1222 vaccine candidate. The vaccine candidate is currently in clinical trials at multiple sites in the UK […]Read More
